Aller au contenu principal
Retour à l'annuaire
Rhumatologue

Docteur MICHEL CHARPENTIER

RPPS 10002002896
📊 Reconnaissance scientifique : 8/100📝 71 articles publiés📚 HAL (4)🏆 1 DU/DIU

✨ Profil synthétique

IA · 06/05/2026

Le Docteur Michel Charpentier est un rhumatologue titulaire d'un Diplôme Universitaire (DU) en Médecine sportive. Il a publié 71 travaux de recherche et possède un h-index de 8 selon OpenAlex. Ses publications sur PubMed sont principalement des revues générales.

Expertises présumées

  • Médecine sportive
  • Pathologies rhumatismales
  • Rééducation fonctionnelle
  • Traumatologie du sport
  • Médecine de la performance
  • Rhumatologie sportive

Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.

Diplômes

🎓 DES & spécialité ordinale

  • Rhumatologie (SM)

🎯 Capacités

  • Médecine appliquée aux sports (C)

🎓 Diplômes

  • DE Docteur en médecine

Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.

Activité de recherche & publications

Source : bases de données publiques (OpenAlex, PubMed).

h-index

8

h articles cités ≥ h fois chacun. Un h de 8 = 8 publications avec 8+ citations.

Citations

241

Publications

71

i10-index

7

Thématiques principales

  • Formal Methods in Verification ×13
  • Logic, programming, and type systems ×12
  • Distributed systems and fault tolerance ×9
  • Advanced Software Engineering Methodologies ×8
  • Opportunistic and Delay-Tolerant Networks ×6

Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.

Bibliographie

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Lieu de consultation

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Articles de presse (4)

Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).

  • Les corps tendres de Michel Charpentier - ArtsHebdoMédias

    📰 ArtsHebdoMédias · 29/07/2023

    <a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxQM2FLTHVRZWc4Tmt4b2NGcGp2TDRwWXBLb01sRm9rcFZFZ0ZlbVJyYXV4YUs5ZGRMOEV4YU9iMFZhdFpkTm96b3FxQk5VV2Q1ZkZ5VHYzMHZtY1Q0Ymx3SXphSVNVR1hQYmVpOV8yOFd5ZTk5eHdNT0dEa1duSF82dXBuTEFDVmM?oc=5" target="_blank">Les corps tendres de Michel Charpentier</a>&

  • Valmondois : Michel Charpentier accueille ses sculptures au jardin - Le Parisien

    📰 Le Parisien · 08/06/2019

    <a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQN1o2RXZyclRxa3VmQ0x2S1Q0WWh0WGxPZGhqV00wM25VWmttckItb0lJX0k0MDhRdjJEUE5McUV6X3h2YUhMenZ6Mms0bFJiMjRRdjNiTy1JaTlTSnRQTkRwQzJPUDY0ZkZUZUY5OHBzYkc1ZHVRbi1lQ0pSb1VwUXVNM3dmRzhLSjJXbEJwekhfaFhINzBCSGEtY0szNjlPWDFvbmR5MmpMcUc4a3BfS3dUb3EtTUJvUW

  • Les deux médecins de Fontenay-sur-Eure « peinés de partir » - L’Écho Républicain

    📰 L’Écho Républicain · 01/07/2015

    <a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxPcmVjbktNMG5nVDZoRlNRbEc1RjBEdVZOMHc3aDRNSVh5QVAtWEUzalprOTZPQzFWUzV6X2NrZ0plZmhvQXRPX1V6b09tcVdodElmdUwyZG56S2hadl9xRFhpRk43ZjlHVVdkbU5xUGpiYXJJdU1FQ0R3dm5tWk41by1pLWdtdkRKeWNKN29aSWZKZ1Rfc2poaGV0b2FNZGhDNlJJSllVclJMTVRmVHFtd0VuRDB2QXdhbW

  • Noël Ballay repose au cimetière communal - L’Écho Républicain

    📰 L’Écho Républicain · 05/11/2021

    <a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOZjg3UW5MTTZWSWVMMEdvMERVblIzQWNHX3g2Nmd6Q0Naa1ZKNzNXSGI1NzJqS0ZOalFZc2xBX1ExbUFsd0xaY25yelVnanhyWW9YS2hxYm9LeTFaZ0pmblJCWmVockRneExZb3M3SEhxQkd1UGh3Vk9DcjFISVpXdkdFYzFXSXRCSjNuTHdoUzBsNkRKVWtfVFVFenpRcE94MWlqT0FrNFZYQXdvLUMzdGRoZEJ4UkxF?o

Top publications · les plus citées

  • 1
    Compliance with pharmacologic therapy for osteoporosis

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2003

    📚 164 citations🎯 RCR 4.82Top 8% NIH
  • 2
    Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes

    Journal of medicinal chemistry · 1995

    📚 95 citations🎯 RCR 2.42Top 21% NIH🔓 Open Access
  • 3
    Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure

    Circulation · 2020

    📚 75 citations🎯 RCR 4.02Top 11% NIH🔓 Open Access📄 PDF gratuit ↗
    Lire l'abstract Crossref ↓

    Background: The cyclic AMP (adenosine monophosphate; cAMP)-hydrolyzing protein PDE4B (phosphodiesterase 4B) is a key negative regulator of cardiac β-adrenergic receptor stimulation. PDE4B deficiency leads to abnormal Ca 2+ handling and PDE4B is decreased in pressure overload hypertrophy, suggesting that increasing PDE4B in the heart is beneficial in heart failure. Methods: We measured PDE4B expression in human cardiac tissues and developed 2 transgenic mouse lines with cardiomyocyte-specific overexpression of PDE4B and an adeno-associated virus serotype 9 encoding PDE4B. Myocardial structure and function were evaluated by echocardiography, ECG, and in Langendorff-perfused hearts. Also, cAMP and PKA (cAMP dependent protein kinase) activity were monitored by Förster resonance energy transfer, L-type Ca 2+ current by whole-cell patch-clamp, and cardiomyocyte shortening and Ca 2+ transients with an Ionoptix system. Heart failure was induced by 2 weeks infusion of isoproterenol or transverse aortic constriction. Cardiac remodeling was evaluated by serial echocardiography, morphometric analysis, and histology. Results: PDE4B protein was decreased in human failing hearts. The first PDE4B-transgenic mouse line (TG15) had a ≈15-fold increase in cardiac cAMP-PDE activity and a ≈30% decrease in cAMP content and fractional shortening associated with a mild cardiac hypertrophy that resorbed with age. Basal ex vivo myocardial function was unchanged, but β-adrenergic receptor stimulation of cardiac inotropy, cAMP, PKA, L-type Ca 2+ current, Ca 2+ transients, and cell contraction were blunted. Endurance capacity and life expectancy were normal. Moreover, these mice were protected from systolic dysfunction, hypertrophy, lung congestion, and fibrosis induced by chronic isoproterenol treatment. In the second PDE4B-transgenic mouse line (TG50), markedly higher PDE4B overexpression, resulting in a ≈50-fold increase in cardiac cAMP-PDE activity caused a ≈50% decrease in fractional shortening, hypertrophy, dilatation, and premature death. In contrast, mice injected with adeno-associated virus serotype 9 encoding PDE4B (10 12 viral particles/mouse) had a ≈50% increase in cardiac cAMP-PDE activity, which did not modify basal cardiac function but efficiently prevented systolic dysfunction, apoptosis, and fibrosis, while attenuating hypertrophy induced by chronic isoproterenol infusion. Similarly, adeno-associated virus serotype 9 encoding PDE4B slowed contractile deterioration, attenuated hypertrophy and lung congestion, and prevented apoptosis and fibrotic remodeling in transverse aortic constriction. Conclusions: Our results indicate that a moderate increase in PDE4B is cardioprotective and suggest that cardiac gene therapy with PDE4B might constitute a new promising approach to treat heart failure.

Publications scientifiques (11) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Transversal10

Revue générale1

Partager cette fiche

in LinkedIn🟢 WhatsApp✉ Email

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.